Trending

Ferring Pharmaceuticals affirmed that the U.S FDA has sanctioned ZOMACTON for injection 5 mg and 10 mg recombinant human growth hormone implied for replacement of GH in adults with GH…
Read More...

QIAGEN N.V forays into an agreement to acquire STAT-Dx to develop the next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes…
Read More...

Authentidate Holding Corp asserted completion of its Corporate name change to Aeon Global Health Corp with  effect immediately. The name change is part of the company's broader…
Read More...

Global provider of cloud-based technology and data analytics for clinical research, Medidata and Syapse partner to transform Oncology Clinical Trials for the age of precision medicine.…
Read More...

Clinical stage biopharmaceutical company focused on developing pharmaceutical therapies based on its proprietary Accordion Pill  platform technology, Intec Pharma appointed R. Michael…
Read More...

Perrigo Company declared having sought tentative U.S FDA approval for the generic version of Soolantra cream,1%. Soolantra cream implied for the treatment of inflammatory lesions of…
Read More...

Microbiome comapany developing customized phage therapies , BiomX Ltd. declared that it has sought sub-license from JSR Corporation a set of bacterial targets for the development and…
Read More...

U.S  Food and Drug Administration conceded to Multi  Radiance Medical's MR4 Laser technology for neck and shoulder pain relief under the Product Classification NHN. MR4 Laser technology…
Read More...

European Organisation for Research and Treatment of Cancer (EORTC) and Foundation Medicine collaborate to ascertain eligibility of patients for oncology clinical Trials of  Foundation…
Read More...

In a bid to commercialize NERLYNX, Puma Biotechnology and Medison Pharma have forayed into an exclusive licensing agreement in Israel as it is currently not approved for…
Read More...

Agilent Technologies ventured into a partnership with Science Exchange to met out Agilent-enabled services to the research community worldwide. Carolina Livi, Ph.D., academic segment…
Read More...

International contract research organization (CRO), Synteract paved way for a new Chief Commercial Officer on board, Jack Shannon. Jack Shannon joins Synteract from Chiltern where he…
Read More...

U.S. Food and Drug Administration (FDA) has approved BioCardia's Investigational Device Exemption for the CardiAMP Chronic Myocardial Ischemia (CMI) Trial to treat patients with…
Read More...

U.S FDA has sanctioned CutisPharma's FIRVANQ (vancomycin hydrochloride) for oral solution, for the treatment of Clostridium difficile associated diarrhea and enterocolitis caused by …
Read More...

electroCore sought 510(k) clearance from the U.S Food and Drug Administration for an extended label for gammaCore (nVNS) as an acute treatment of pain associated with migraine in adult…
Read More...

Dragonfly Therapeutics welcomes on board Dr. Jean-Marie Cuillerot, MD as its Chief Medical Officer. Dr. Cuillerot set to spearhead clinical development of Dragonfly's natural Killer…
Read More...

Global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, QT Vascular successfully…
Read More...

Wuxi Biologics and Aravive Biologics collaborate to extend their biologics manufacturing collaboration, based on the rapid success achieved in the process development, scale-up and cGMP…
Read More...

Clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, SillaJen declared the commencement of Phase 1/2 clinical trial of…
Read More...

For routine prophylaxis of bleeding episodes in people with hemophilia A with factor VIII inhibitors, Chugai Pharmaceuticals sought positive response from EU Committee for Medicinal…
Read More...